The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer-Reference-Cited by-同舟云学术

The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer

Published:2023-06-29 Issue:8 Volume:64 Page:1238-1243
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Hagens Marinus J.,Luining Wietske I.,Jager Auke,Donswijk Maarten L.,Cheung Zing,Wondergem Maurits,Oprea-Lager Daniela E.,Vis André N.,van Leeuwen Pim J.,van der Poel Henk G.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference29 articles.

1. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

2. Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study;Donswijk;BMC Cancer.,2020

3. Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer;Yaxley;BJU Int.,2019

4. Ga-68-PSMA PET/CT in treatment-naïve patients with prostate cancer: which clinical parameters and risk stratification systems best predict PSMA-positive metastases?;Rogasch;Prostate.,2018

5. 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancer;Dekalo;Can Urol Assoc J.,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of 68Ga-PSMA PET/CT in the diagnosis of intracapsular prostate cancer with a poor prognosis;Discover Oncology;2024-07-02

2. A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer;European Urology Oncology;2024-05

3. The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer;European Urology Open Science;2024-01

4. Assessing Metastasis through Positron Emission Tomography (PET): An In-depth Analysis and Mapping of Thematic Clusters and Prevailing Topics in Nuclear Medicine Research;Medical Science and Discovery;2023-10-11

5. Histopathological concordance between prostate biopsies and radical prostatectomy specimens—implications of transrectal and transperineal biopsy approaches;Prostate Cancer and Prostatic Diseases;2023-09-02